Esmo Open, Esmo Open, 6(3), p. e000408, 2018
DOI: 10.1136/esmoopen-2018-000408
Full text: Unavailable
Phase I of the Cancer Research UK Stratified Medicine Programme (SMP1) was designed to roll out molecular pathology testing nationwide at the point of cancer diagnosis, as well as facilitate an infrastructure where surplus cancer tissue could be used for research. It offered a non-trial setting to examine common UK cancer genetics in a real-world context.